AIM
NVO

Anchor Investment Management’s Novo Nordisk NVO Stock Holding History

Anchor Investment Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-5,000
Closed -$209 – 962
2021
Q2 		$209 Buy
+5,000
New +$194K ﹤0.01% 941

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Anchor Investment Management's NVO Position: Q1 2026 in Review

Anchor Investment Management reduced its Novo Nordisk (NVO) stake by 1.8% in Q1 2026, selling an estimated $10.8K and leaving 12,579 shares worth $462K. The position accounts for 0.04% of the portfolio, ranked #274.

Anchor Investment Management first reported a position in NVO in Q1 2016 and has held it in 41 quarters since. The position peaked at $1.88M in Q2 2024. 1,276 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Anchor Investment Management held 12,579 shares of Novo Nordisk worth $462K as of Q1 2026.
  • Anchor Investment Management sold 228 Novo Nordisk shares in Q1 2026, an estimated $10.8K.
  • Novo Nordisk made up 0.04% of Anchor Investment Management's portfolio in Q1 2026, its #274 holding.
  • Anchor Investment Management first reported a position in Novo Nordisk in Q1 2016 and has held it in 41 quarters since.
  • Anchor Investment Management's Novo Nordisk position peaked at $1.88M in Q2 2024.
  • 1,276 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Anchor Investment Management's 13F filing for Q1 2026, filed 1 May 2026.